Jay A. Fishman Ltd’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.4M	Buy	566,730 +2,080	+0.4%	+$53.1K	1.19%	22
2025 Q4	$16.4M	Sell	564,650 -1,000	-0.2%	-$25.6K	1.35%	20
2025 Q3	$10.7M	Buy	565,650 +9,500	+2%	+$150K	0.91%	25
2025 Q2	$7.8M	Buy	556,150 +23,000	+4%	+$322K	0.75%	25
2025 Q1	$8.34M	Sell	533,150 -3,250	-0.6%	-$45.8K	0.91%	20
2024 Q4	$7.47M	Buy	536,400 +118,400	+28%	+$1.3M	0.7%	22
2024 Q3	$3.89M	Buy	418,000 +71,400	+21%	+$705K	0.39%	31
2024 Q2	$3.22M	Buy	346,600 +122,300	+55%	+$1.11M	0.34%	31
2024 Q1	$2.22M	Buy	224,300 +171,300	+323%	+$1.28M	0.25%	35
2023 Q4	$171K	Sell	53,000 -34,000	-39%	-$92.4K	0.02%	89
2023 Q3	$462K	Buy	87,000 +10,000	+13%	+$85K	0.06%	66
2023 Q2	$734K	Buy	77,000 +13,200	+21%	+$147K	0.09%	56
2023 Q1	$702K	Buy	63,800 +20,000	+46%	+$289K	0.09%	55
2022 Q4	$648K	Sell	43,800 -3,000	-6%	-$52.4K	0.09%	58
2022 Q3	$894K	Buy	46,800 +25,800	+123%	+$585K	0.13%	50
2022 Q2	$448K	Buy	+21,000	New	+$431K	0.06%	68